James Lutterbaugh
Impact in
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer
- Molecular Biology top 2%
- TGF-β signaling in diseases
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
Papers in
-
- Genetic factors in colorectal cancer 17
-
- Epigenetics and DNA Methylation 8
- TGF-β signaling in diseases 5
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Sanford D. Markowitz (32 shared papers)Lois L. Myeroff (9 shared papers)James K. V. Willson (12 shared papers)Kenneth W. Kinzler (4 shared papers)Ramon E. Parsons (2 shared papers)Bert Vogelstein (3 shared papers)Michael G. Brattain (2 shared papers)Jing Wang (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (8 papers)Gastroenterology (3 papers)Science (2 papers)Oncogene (2 papers)Genome Medicine (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
James Lutterbaugh
35 papers receiving 5.9k citations
James Lutterbaugh's Hit Papers
Peers
Comparison fields: 5 of 89
- Pathology and Forensic Medicine 2k
- Molecular Biology 2.9k
- Oncology 959
- Cancer Research 466
- Pharmacology 232
Countries citing papers authored by James Lutterbaugh
This map shows the geographic impact of James Lutterbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lutterbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lutterbaugh more than expected).
Fields of papers citing papers by James Lutterbaugh
This network shows the impact of papers produced by James Lutterbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lutterbaugh. The network helps show where James Lutterbaugh may publish in the future.
Co-authors
The 25 scholars most cited alongside James Lutterbaugh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability Hit paper breakdown → | 1995 | 1978 |
| 2 | Biallelic inactivation of hMLH 1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers Hit paper breakdown → | 1998 | 543 |
| 3 | A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. | 1995 | 404 |
| 4 | Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. | 1999 | 328 |
| 5 | 2005 | 312 | |
| 6 | 2003 | 262 | |
| 7 | 2012 | 261 | |
| 8 | 2004 | 215 | |
| 9 | 2001 | 196 | |
| 10 | 2014 | 174 | |
| 11 | 2009 | 134 | |
| 12 | 2018 | 133 | |
| 13 | Silence of chromosomal amplifications in colon cancer. | 2002 | 126 |
| 14 | 2015 | 106 | |
| 15 | 2003 | 96 | |
| 16 | 2009 | 85 | |
| 17 | 2001 | 81 | |
| 18 | PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. | 2003 | 80 |
| 19 | 2013 | 79 | |
| 20 | Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. | 2001 | 65 |
About James Lutterbaugh
James Lutterbaugh is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Pharmacology and Neurology, having authored 36 papers that have together received 6.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (17 papers), Epigenetics and DNA Methylation (8 papers), TGF-β signaling in diseases (5 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Genomic variations and chromosomal abnormalities (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (2k citations), Molecular Biology (2.9k citations), Oncology (959 citations), Cancer Research (466 citations) and Pharmacology (232 citations). James Lutterbaugh has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Sanford D. Markowitz, Lois L. Myeroff, James K. V. Willson, Kenneth W. Kinzler, Ramon E. Parsons, Bert Vogelstein, Michael G. Brattain, Jing Wang, Lu‐Zhe Sun and Robert S. Fan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gastroenterology, Science, Oncogene and Genome Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.